TTD | Drug: D05YQL

Drug General Information
Drug ID	D05YQL
Former ID	DIB011681
Drug Name	BM-ca
Synonyms	Anti-CD20 antibodies (lymphoma), BioMedics
Drug Type	Antibody
Indication	Non-hodgkin's lymphoma [ICD10:C85]		Phase 1	[549211]
Company	BioMedics Japan Inc
Target and Pathway
Target(s)	B-lymphocyte antigen CD20	Target Info		[531291]
KEGG Pathway	Hematopoietic cell lineage
References
Ref 549211	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033790)
Ref 531291	BM-ca is a newly defined type I/II anti-CD20 monoclonal antibody with unique biological properties. Int J Oncol. 2011 Feb;38(2):335-44.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

Drug Information